Entasis Therapeutics
Andrew F. Shorr, MD, MPH, is Director of Pulmonary and Critical Care at the Washington Hospital Center and Professor of Medicine at Georgetown University. He received his undergraduate degree (public policy) from Princeton University, an MPH from Johns Hopkins University, and his medical degree from the University of Virginia. He is currently completing his MBA studies at the Darden School of Business at the Univ. of Virginia. Dr Shorr’s research interests address healthcare outcomes, epidemiology in pulmonology/critical care, and infection in the hospitalized patient. He is specifically focused currently on issues related to anti-infective resistance, novel clinical trial designs, and the unmet need for new therapies. Dr Shorr is the author/co-author of nearly 300 peer-reviewed manuscripts and book chapters. He has served on the editorial board of Chest, currently serves on the editorial board of Critical Care Medicine, and is a reviewer on several medical and critical care journals. He also served as a Fullbright Specialist Scholar in Australia in 2010 and recently won the Sol Katz Award for Excellence in Teaching from the American College of Physicians.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Entasis Therapeutics
Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients.